AbbVie Ventures
2 rounds tracked since 28 October 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $105M
Sectors
Countries
Rounds
- PsiTheraDevelops oral medicines for immune and inflammatory diseases $25M10 Nov
- Zag BioThymus-targeting antibodies to restore immune tolerance in autoimmune disease $80MSeries A · 28 Oct
No round matches these filters.